Revelation Biosciences (REVB) Assets (2020 - 2026)
Revelation Biosciences (REVB) posted quarterly Assets of $11.6 million for Q4 2025, up 74.91% year-over-year from $6.6 million in Q4 2024, and down 9.9% quarter-over-quarter from $12.9 million in Q3 2025.
Revelation Biosciences (REVB) Assets (2020 - 2026) Analysis & Trends
Revelation Biosciences (REVB) has reported Assets for 6 consecutive years, with $11.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets rose 74.91% year-over-year to $11.6 million; the TTM figure through Dec 2025 stood at $11.6 million (up 74.91% YoY), while the FY2025 annual figure was $11.6 million, up 74.91% from the prior year.
- Assets eased to $11.6 million in Q4 2025 per REVB's latest filing, from $12.9 million in the prior quarter.
- Across five years, Assets topped out at $74.0 million in Q1 2021 and bottomed at $2.0 million in Q4 2021.
- Historically, Assets has averaged $19.1 million across 5 years, with a median of $11.9 million in 2023.
- On a YoY basis, Assets climbed as much as 2002.15% in 2021 and fell as far as 97.25% in 2021.
- Revelation Biosciences' Assets stood at $2.0 million in 2021, then soared by 169.48% to $5.5 million in 2022, then jumped by 121.91% to $12.2 million in 2023, then slumped by 45.78% to $6.6 million in 2024, then soared by 74.91% to $11.6 million in 2025.
- Business Quant data shows REVB's Assets at $11.6 million in Q4 2025, $12.9 million in Q3 2025, and $5.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Revelation Biosciences | 4.17 Mn | -7.33 Mn | - | 12.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.50 Mn |
| Dec 31, 2025 | 11.58 Mn |
| Sep 30, 2025 | 12.86 Mn |
| Jun 30, 2025 | 5.40 Mn |
| Mar 31, 2025 | 3.97 Mn |
| Dec 31, 2024 | 6.62 Mn |
| Sep 30, 2024 | 6.74 Mn |
| Jun 30, 2024 | 12.27 Mn |
| Mar 31, 2024 | 14.70 Mn |
| Dec 31, 2023 | 12.21 Mn |
| Sep 30, 2023 | 14.22 Mn |
| Jun 30, 2023 | 16.04 Mn |
| Mar 31, 2023 | 18.12 Mn |
| Dec 31, 2022 | 5.50 Mn |
| Sep 30, 2022 | 6.60 Mn |
| Jun 30, 2022 | 4.15 Mn |
| Mar 31, 2022 | 7.98 Mn |
| Dec 31, 2021 | 2.04 Mn |
| Sep 30, 2021 | 73.56 Mn |
| Jun 30, 2021 | 73.89 Mn |